CTRV Stock Forecast and Price Target (ContraVir Pharmaceuticals Inc stock)

CTRV Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -24.68% during the next 3 months and, with a 90% probability hold a price between $0.91 and $1.31 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$1.20	$1.46	$1.73
2021-09-21	$1.19	$1.45	$1.72
2021-09-22	$1.18	$1.45	$1.71
2021-09-23	$1.17	$1.44	$1.70
2021-09-24	$1.16	$1.43	$1.69
2021-09-27	$1.16	$1.42	$1.68
2021-09-28	$1.15	$1.41	$1.67
2021-09-29	$1.14	$1.40	$1.66
2021-09-30	$1.13	$1.39	$1.65
2021-10-01	$1.12	$1.38	$1.65
2021-10-04	$1.11	$1.37	$1.64
2021-10-05	$1.10	$1.36	$1.63
2021-10-06	$1.09	$1.36	$1.62
2021-10-07	$1.08	$1.35	$1.61
2021-10-08	$1.07	$1.34	$1.60
2021-10-11	$1.06	$1.33	$1.59
2021-10-12	$1.06	$1.32	$1.58
2021-10-13	$1.05	$1.31	$1.57
2021-10-14	$1.04	$1.30	$1.56
2021-10-15	$1.03	$1.29	$1.56
2021-10-18	$1.02	$1.28	$1.55
2021-10-19	$1.01	$1.27	$1.54
2021-10-20	$1.00	$1.27	$1.53
2021-10-21	$0.99	$1.26	$1.52
2021-10-22	$0.98	$1.25	$1.51
2021-10-25	$0.97	$1.24	$1.50
2021-10-26	$0.97	$1.23	$1.49
2021-10-27	$0.96	$1.22	$1.48
2021-10-28	$0.95	$1.21	$1.47
2021-10-29	$0.94	$1.20	$1.47

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!